Sildenafil and Uteroplacental Perfusion

Clinical trial NCT01107782 · UNKNOWN

Trial details

NCT number: NCT01107782
Sponsor: Tehran University of Medical Sciences
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Fetal Growth Retardation

Start date: 2008-06-01
Primary completion: 2010-06-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.